2020 Frontiers in Academic Pathology: Transplant & Therapeutic Pathology

Friday, January 31, 2020, 8:00 AM - 6:00 PM, New York Academy of Medicine


The 2020 Frontiers in Academic Pathology series will focus on Transplant & Therapeutic Pathology. Presentations by leading experts in Immunogenetics, Immunotheapy, Transplantation, and Transfusion Medicine ll update the audience on state-of-the-art diagnostic services and therapeutic modalities regarding organ transplantation, graft-versus-host disease, and cell-based therapeutics, including stem cell transplant and immunotherapies.

1. Describe the use and limitations of diagnostic modalities and biomarkers in the management of patients undergoing cell-based and organ transplantation.
2. Describe recent and developing approaches toward HLA typing.
3. Describe novel clinical applications of cell-based diagnostics and treatments.
4. Describe developing legislation, regulatory and ethical guidelines for the use of human cells or tissue in implantation, transplantation, or transfer into a human recipient.

All Residents/Fellows/Trainees are complimentary. Please email [email protected] a copy of your hospital ID badge to receive a complimentary code.

The Icahn School of Medicine at Mount Sinai is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

AMA PRA Category 1 Credits™ (7.25 hours)

You are not logged in.

Please click the button below to login or create a new account before continuing.

It is the policy of the Icahn School of Medicine at Mount Sinai to ensure objectivity, balance, independence, transparency, and scientific rigor in all CME-provided educational activities. All faculty participating in the planning or implementation of a provided activity are expected to disclose to the audience any relevant financial relationships and to assist in resolving any conflict of interest that may arise from the relationship. Presenters must also make a meaningful disclosure to the audience of their discussions of unlabeled or unapproved drugs or devices. This information will be available as part of the course material.

Friday, January 31, 2020